| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.38 | 5e-10 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.39 | 1e-09 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.25 | 0.0002 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.21 | 0.0004 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.17 | 0.004 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.19 | 0.004 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.16 | 0.02 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.18 | 0.02 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.16 | 0.02 |